Business
ScottsMiracle-Gro CEO Expresses Support for President’s Cannabis Rescheduling Executive Order
CEO says move enhances company’s broader growth strategyMARYSVILLE, Ohio, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today expressed support for President Trump’s executive order to reschedule cannabis from a Schedule I to Schedule III drug. “With 39 states already legalizing cannabis in some form, rescheduling to a lower level drug on the federal level has been long overdue,” s
About this update from Scotts Miracle-gro Company (the)
[{"type":"image","alt":"Scotts Miracle-Gro Company (The)","displaySize":"","headline":null,"caption":"Scotts Miracle-Gro Company (The)","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":46,"url":"https://media.zenfs.com/en/globenewswire.com/4777d6ddab10efde268d635a6f8d944c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Dll4YlLPb19rOgMVTumO7Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTY0O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/4777d6ddab10efde268d635a6f8d944c","width":300,"height":46}},"lazy":false},{"type":"text","content":"CEO says move enhances company’s broader growth strategy","length":56,"tagName":"p"},{"type":"text","content":"MARYSVILLE, Ohio, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The Scotts Miracle-Gro Company (NYSE: SMG), the leading marketer of branded consumer lawn and garden products in North America, today expressed support for President Trump’s executive order to reschedule cannabis from a Schedule I to Schedule III drug.","length":304,"tagName":"p"},{"type":"text","content":"“With 39 states already legalizing cannabis in some form, rescheduling to a lower level drug on the federal level has been long overdue,” said Chairman and CEO Jim Hagedorn. “President Trump deserves credit and praise for taking this bold action, as it reflects the will of the people and sets the stage for much-needed research into the medical use of cannabis.”","length":363,"tagName":"p"},{"type":"text","content":"“Just as importantly, this will help deliver a blow to the illicit cannabis market by strengthening the financial viability of the legal and regulated industry that employs over 425,000 people and contributes $100 billion to the economy.”","length":238,"tagName":"p"},{"type":"text","content":"Hagedorn said it is important to note that rescheduling does not legalize cannabis on a federal level but rather removes undue financial constraints on cannabis companies and makes it easier for medical research to be conducted on the use of cannabis in treating PTSD, cancer and other health conditions. Under Schedule I, research is limited and cannabis companies have been subjected to the 280E tax penalty, which prohibits the deduction of business expenses and results in tax rates of 70 percent or higher compared to the general corporate tax rate of 21 percent.","length":568,"tagName":"p"},{"type":"text","content":"“The 280...